Article

Atrix granted stay in patent infringement case over LHRH therapy

The U.S. District Court for the Northern District of Illinois has issued an order granting Atrix Laboratories' motion to stay the patent infringement suit filed by TAP Pharmaceutical Products, Inc., Takeda Chemical Industries, Ltd., and Wako Pure Chemical Industries, Ltd., according to an Atrix press release.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.